Patent · US Expired

Vaccine against mumps containing a jeryl-lynn virus strain

US6899884B2 · kind B2 · utility

0Cited by

3References

6Claims

0Family size

Assignee

SmithKline Beecham Biologicals S.A. · BE

Inventors

Nigel Harford · Overijse, BE
Brigitte Desiree Alberte Colau · Genval, BE
Jean Didelez · Court-Saint-Etienne, BE

Key dates

Filing date	Nov 3, 2003
Grant date	May 31, 2005
Priority date	—
Expiry date	Nov 3, 2023

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A new mumps vaccine is presented, comprising a homogeneous pure isolate derived from the Jeryl-Lynn strain of mumps virus. In a preferred embodiment of the invention the vaccine produces higher seroconversion and anitbody titres than know commercial vaccines.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.